SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-001737
Filing Date
2022-01-20
Accepted
2022-01-20 17:01:24
Documents
14
Period of Report
2022-01-14
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43567
2 ex10-1.htm EX-10.1 22964
  Complete submission text file 0001493152-22-001737.txt   302615

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE foxwu-20220114.xsd EX-101.SCH 4142
4 XBRL DEFINITION FILE foxwu-20220114_def.xml EX-101.DEF 27724
5 XBRL LABEL FILE foxwu-20220114_lab.xml EX-101.LAB 38473
6 XBRL PRESENTATION FILE foxwu-20220114_pre.xml EX-101.PRE 26335
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7005
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39891 | Film No.: 22542988
SIC: 2834 Pharmaceutical Preparations